Skip to main content
CRDF logo
CRDF
(NASDAQ)
Cardiff Oncology, Inc.
$1.21-- (--)
Loading... - Market loading

Cardiff Oncology (CRDF) Stock Price & Financial Analysis

Cardiff Oncology Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$1.24 - $1.32
52-Week High$4.56
52-Week Low$1.16
Open$1.26
Volume976.02K
Average Volume (3M)1.54M
Market Cap82.70M
Shares Outstanding68.35M
Price to Sales (P/S)157.53
Price to Book (P/B)2.38
EV/EBITDA-1.65
Revenue (TTM)525.00K
Net Income (TTM)-44.76M
Free Cash Flow (TTM)-37.46M
EPS (TTM)$-0.67
Profit Margin-8526.10%
Operating Margin-9033.90%
Return on Equity (ROE)-128.96%
Debt to Equity0.02
50-Day MA$1.61
200-Day MA$2.01
52-Week Change-60.97%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Cardiff Oncology

What is the current stock price for CRDF?

As of the latest trading session, CRDF stock trades at $1.26. The 52-week range is $1.16–$4.56, with a day range of $1.24–$1.32.

What is the P/E ratio for CRDF?

The P/E ratio (Price-to-Earnings) for CRDF is shown in the Key Statistics section. This valuation metric helps compare Cardiff Oncology, Inc. to industry peers.

Does CRDF pay dividends?

Cardiff Oncology does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for CRDF?

Based on 7 analysts, the consensus for CRDF is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of CRDF?

Cardiff Oncology's market capitalization is $86.1M, classifying it as a micro-cap company. Cardiff Oncology operates in the Healthcare sector within the Biotechnology industry.